International Business MachinesIBM's subsidiary Anderon finalized a $1 billion CHIPS Act R&D award, with IBM adding $1 billion of its own money.
Anderon, an IBM subsidiary, finalized a $1 billion research-and-development award from the U.S. Department of Commerce on Wednesday under the 2022 CHIPS and Science Act. The funding will support Anderon's efforts to advance quantum wafer manufacturing at its facility in Albany, New York, where a 300-millimeter quantum wafer foundry serves customers across the quantum industry. IBM has put up $1 billion of its own money alongside the federal award, and production is underway with quantum wafers already in process. The Anderon award is part of a broader $2 billion package distributed across nine quantum computing companies under the CHIPS and Science Act, with GlobalFoundries in line for $375 million and D-Wave Quantum, Rigetti Computing, and Infleqtion each expected to receive $100 million; each of the nine firms will give the federal government a minority ownership stake in exchange for the funding. The finalization follows a letter of intent between IBM and the Commerce Department announced in May, and last week Rigetti Computing, D-Wave Quantum, and Quantinuum each finalized $100 million deals with the department. IBM stock fell 3.3% on Wednesday and has declined nearly 19% this year.
International Business MachinesIBM's subsidiary Anderon finalized a $1 billion CHIPS Act R&D award, with IBM adding $1 billion of its own money.
Infleqtion, Inc.Infleqtion is expected to receive $100 million under the CHIPS Act quantum funding package.
D-Wave Quantum Inc. Common StockD-Wave Quantum is expected to receive $100 million under the CHIPS Act quantum package and recently finalized its deal.
Rigetti Computing IncRigetti Computing finalized its $100 million CHIPS Act award last week as part of the same package.
Quantinuum Inc. Class A Common Stock
Globalfoundries IncGlobalFoundries is in line for $375 million under the same CHIPS Act quantum funding package.